IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MEOLA, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.580
EU - Europa 17.197
AS - Asia 12.465
Continente sconosciuto - Info sul continente non disponibili 2.352
SA - Sud America 1.331
AF - Africa 214
OC - Oceania 123
Totale 52.262
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.748
GB - Regno Unito 5.171
IT - Italia 4.184
CN - Cina 3.658
SG - Singapore 3.466
DE - Germania 1.602
RU - Federazione Russa 1.252
SE - Svezia 1.102
HK - Hong Kong 1.030
BR - Brasile 889
FR - Francia 849
BD - Bangladesh 848
VN - Vietnam 777
IN - India 624
CA - Canada 597
TR - Turchia 578
UA - Ucraina 577
NL - Olanda 557
KR - Corea 489
IE - Irlanda 471
FI - Finlandia 459
JP - Giappone 308
EU - Europa 304
ID - Indonesia 209
CO - Colombia 204
ES - Italia 190
PL - Polonia 115
MX - Messico 109
BE - Belgio 104
AU - Australia 103
GR - Grecia 99
AR - Argentina 77
CH - Svizzera 63
PT - Portogallo 59
DK - Danimarca 55
PH - Filippine 55
IQ - Iraq 54
TW - Taiwan 52
RO - Romania 48
EC - Ecuador 43
ZA - Sudafrica 43
CZ - Repubblica Ceca 42
AT - Austria 40
MY - Malesia 37
PK - Pakistan 37
CI - Costa d'Avorio 35
CL - Cile 35
EG - Egitto 31
NO - Norvegia 31
UZ - Uzbekistan 30
VE - Venezuela 30
IR - Iran 25
IL - Israele 24
PE - Perù 24
SA - Arabia Saudita 24
HU - Ungheria 22
TN - Tunisia 21
CR - Costa Rica 19
JM - Giamaica 19
KE - Kenya 19
RS - Serbia 19
TH - Thailandia 19
PY - Paraguay 18
HN - Honduras 17
NZ - Nuova Zelanda 17
AE - Emirati Arabi Uniti 16
BG - Bulgaria 16
JO - Giordania 13
TT - Trinidad e Tobago 13
DZ - Algeria 12
GT - Guatemala 11
KZ - Kazakistan 11
SI - Slovenia 11
AZ - Azerbaigian 10
HR - Croazia 10
MA - Marocco 10
NP - Nepal 10
EE - Estonia 9
LU - Lussemburgo 8
SV - El Salvador 8
AL - Albania 7
BY - Bielorussia 7
QA - Qatar 7
AM - Armenia 6
BJ - Benin 6
BO - Bolivia 6
CY - Cipro 6
LB - Libano 6
OM - Oman 6
PA - Panama 6
DO - Repubblica Dominicana 5
ET - Etiopia 5
NI - Nicaragua 5
SC - Seychelles 5
SN - Senegal 5
UY - Uruguay 5
BS - Bahamas 4
KG - Kirghizistan 4
LT - Lituania 4
LV - Lettonia 4
Totale 50.134
Salva come PNG Salva come JPEG
Città #
Southend 4.474
Singapore 1.868
Ashburn 1.761
Chandler 1.120
Seattle 984
Milan 974
Hong Kong 957
San Jose 885
Council Bluffs 760
Beijing 717
Fairfield 662
Princeton 656
Wilmington 618
Santa Clara 492
Dublin 458
Dallas 422
Jacksonville 399
Woodbridge 397
Dearborn 379
Los Angeles 364
Houston 327
Mountain View 326
Ann Arbor 317
Redmond 307
Rome 275
Cambridge 272
Bengaluru 269
Nanjing 254
Toronto 240
Lauterbourg 234
Redwood City 225
Ho Chi Minh City 224
Somerville 223
New York 210
Serra 208
Boardman 194
Sakarya 190
Hanoi 182
Buffalo 181
Guangzhou 181
Hefei 177
Helsinki 174
Des Moines 168
Frankfurt am Main 167
Bogotá 164
Moscow 162
Andover 158
Shanghai 146
The Dalles 127
Columbus 123
Phoenix 120
Tokyo 118
Jakarta 117
Pisa 112
Hamburg 96
Jinan 95
Shenyang 93
Eitensheim 90
São Paulo 89
Athens 88
Cangzhou 86
London 85
Warsaw 81
Nanchang 80
Chicago 79
Berlin 77
Seoul 77
Sunnyvale 69
Tianjin 68
Turin 67
Ottawa 66
Munich 65
Bologna 64
Changsha 61
Medford 61
Naples 60
Brussels 55
Shenzhen 55
Hanover 53
Hebei 53
San Diego 50
Vigo 49
Grafing 46
Atlanta 45
Bitonto 44
Florence 44
Montreal 44
Washington 43
Hangzhou 42
Boston 41
Falls Church 39
Dong Ket 37
Jiaxing 36
Abidjan 35
Nuremberg 35
Odernheim 35
Paris 35
Norwalk 34
Brooklyn 33
Taipei 33
Totale 28.932
Salva come PNG Salva come JPEG
Nome #
The progression of Muscular Impairment Rating Scale (MIRS) and the development of cardiac conduction abnormalities in DM1 709
Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2 681
Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2 617
Cerebral involvement in myotonic dystrophies 580
The analysis of myotonia congenita mutations discloses functional clusters of amino acids within the CBS2 domain and the C-terminal peptide of the ClC-1 channel 551
Electromechanical delay components during skeletal muscle contraction and relaxation in patients with myotonic dystrophy type 1 538
Increased visceral adipose tissue rather than BMI as a risk factor for dementia 483
Andersen's syndrome : a distinct periodic paralysis 482
DM1, DM2 e paralisi periodiche : diagnosi e terapia 472
Cognitive impairment in adult myotonic dystrophies : a longitudinal study 451
Atipica presentazione di sclerosi multipla alla RMN : un caso di difficile diagnosi differenziale 445
Italian validation of INQoL, a quality of life questionnaire for adults with muscle diseases 406
La canalopatia del cloro : diagnosi clinica differenziale 403
Hypokalemic periodic paralysis in a patient with acquired growth hormone deficiency 402
Treatment for periodic paralysis 390
Colocalization of ribonuclear inclusions with muscle blind like-proteins in a family with myotonic dystrophy type 2 associated with a short CCTG expansion 381
Neuropsychological and psychological functioning aspects in myotonic dystrophy type 1 patients in Italy 352
Tolerability and safety of mexiletine in patients with myotonia dystrophy type 1 over time 349
Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1 340
Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy 327
Electromechanical delay components during skeletal muscle contraction and relaxation : novel physiological insights and possible application in Myotonic Dystrophies 319
Myotonia congenita : novel mutations in CLCN1 gene and functional characterizations in Italian patients 315
A newly-described myotonic disorder (proximal myotonic myopathy--PROMM): personal experience and review of the literature 314
Case report: Sodium and chloride muscle channelopathy coexistence: A complicated phenotype and a challenging diagnosis 307
Overexpression of CUGBP1 in Skeletal Muscle from Adult Classic Myotonic Dystrophy Type 1 but Not from Myotonic Dystrophy Type 2 305
Long-term follow-up free of ventricular fibrillation recurrence after resuscitated cardiac arrest in a myotonic dystrophy type 1 patient 300
Genome wide identification of aberrant alternative splicing events in myotonic dystrophy type 2 299
Clinical factors associated with statins prescription in acute ischemic stroke patients : findings from the Lombardia Stroke Registry 297
Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect 296
Deregulated MicroRNAs in Myotonic Dystrophy Type 2 294
Circulating irisn is reduced in male patients with type 1 and type 2 Myotonic Dystrophies 287
Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy 286
Gonadal failure is associated with visceral adiposity in myotonic dystrophies 285
Mexiletine Improves Symptoms and Signs of Myotonia in Non-dystrophic Myotonia 284
Premature senescence in primary muscle cultures of myotonic dystrophy type 2 is not associated with p16 induction 279
Therapy in myotonic disorders and in muscle channelopathies 275
High-sensitive cardiac troponin T (hs-cTnT) assay as serum biomarker to predict cardiac risk in myotonic dystrophy : A case-control study 273
"I know that you know that I know" : Neural substrates associated with social cognition deficits in DM1 patients 271
Status update and interim results from the Asymptomatic Carotid Surgery Trial-2 (ACST-2) 269
Sodium Channel Myotonia Due to Novel Mutations in Domain I of Nav1.4 269
Concurrence of facioscapulohumeral muscular dystrophy and myasthenia gravis 267
RNA transcription and maturation in skeletal muscle cells are similarly impaired in myotonic dystrophy and sarcopenia : the ultrastructural evidence 267
Bimodal administration of entacapone in Parkinson's disease patients improves motor control 264
Muscle cramps, insuline resistance, acanthosis nigricans and acral hypertrphy sindrome : a potentially treatable condition 260
A family with an unusual myotonic and myopathic phenotype and no CTG expansion (proximal myotonic myopathy syndrome): a challenge for future molecular studies 260
Receptor and post-receptor abnormalities contribute to insulin resistance in myotonic dystrophy type 1 and type 2 skeletal muscle 258
Persistent autobiographical amnesia: a case report 256
Studio longitudinale del coinvolgimento muscolare e cardiaco nella Distrofia Miotonica di tipo 1 (DM1) e di tipo 2 (DM2) 254
Vitamin D, parathyroid hormone and muscle impairment in myotonic dystrophies 251
The role of clinical and neuroimaging features in the diagnosis of CADASIL 249
Oculopharyngeal muscular dystrophy in Italy. 244
Mutation in the S4 segment of the adult skeletal sodium channel gene in an Italian paramyotonia congenita (PC) family 244
Development and validation of a new molecular diagnostic assay for detection of myotonic dystrophy type 2 240
Tibialis anterior muscle needle biopsy and sensitive biomolecular methods : a useful tool in myotonic dystrophy type 1 239
Amyotrophic lateral sclerosis presenting during pregnancy : report of clinical and genetic features of three cases 238
Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2 238
Consensus-based care recommendations for adults with myotonic dystrophy type 1. 237
Endocrine alterations in myotonic dystrophy type 1 and type 2 : correlation with markers of muscle fiber atrophy 236
Fragility fractures and bone mineral density in male patients affected by type 1 and type 2 myotonic dystrophy 233
Alterazioni proteine tau liquorali e quoziente intellettivo (QI) nelle Distrofie Miotonichew di tipo 1 (DM1) e di tipo 2 (DM2). 230
Pathogenic role of ribonuclear inclusions in myotonic dystrophy type 2: myth or reality? 228
Lezioni di Traumatologia 228
Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis 228
Proteome profile in Myotonic Dystrophy type 2 myotubes reveals dysfunction in protein processing and mitochondrial pathways 226
Redefining clinical phenotype in a large color of Italian non-dystrophic myotonic patients. 225
Myotonia permanens with neonatal onset associated with a p.Gly1306Glu mutation in the SCN4A gene. 224
Electromechanical delays during a fatiguing exercise and recovery in patients with myotonic dystrophy type 1 223
Cerebrospinal fluid (CSF) tau and amyloid beta42 (A beta 42) protein abnormalities correlate with executive dysfunction in myotonic dystrophy type 1 (DM1) and type 2 (DM2) 222
Plasma microRNAs as biomarkers for myotonic dystrophy type 1 221
Biomolecular diagnosis of myotonic dystrophy type 2 : a challenging approach 221
Unusual diagnostic and management problems in neuromuscular disease : Gitelman Syndrome 220
Abnormalities of proliferative and differentiative properties in DM1 and DM2 senescence myoblasts -in vitro- 220
A CASE OF MITOCHONDRIAL MYOPATHY, LACTIC-ACIDOSIS AND COMPLEX-I DEFICIENCY 219
Quantitative myotonia assessment: an experimental protocol 219
Rare Disease : Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1 217
Computerized tomography and magnetic resonance muscle imaging in Miyoshi's myopathy 216
Myotonic dystrophies : state of the art of new therapeutic developments for the CNS 216
Progression of muscle histopathology but not of spliceopathy in myotonic dystrophy type 2 214
Clinical Reasoning : a 35-year-old woman with hyperstartling, stiffness, and accidental falls : a startling diagnosis 214
Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1(DM-1) and in proximal myotonic myopathy (PROMM/DM-2) 207
Electrophysiology study protocol of arrhythmias in myotonic dystrophy type 1 and type 2 206
Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies 206
High prevalence of vitamin D deficiency in myotonic dystrophies 203
Muscle biopsy and cell cultures: potential diagnostic tools in hereditary skeletal muscle channelopathies 202
Case report: Multiple approach analysis in a case of clinically assessed myotonia congenita 201
Gene expression analysis in Myotonic Dystrophy : indications for a common molecular pathogenic pathway in DM1 and DM2 201
New mutations in SCN4A and their biophysical properties 201
A clinical, genetic and biochemical characterization of SPG7 mutations in a large cohort of patients with hereditary spastic paraplegia 199
Co-occurrence of DMPK expansion and CLCN1 mutation in a patient with myotonia 198
RNA/MBNL1-containing foci in myoblast nuclei from patients affected by myotonic dystrophy type 2 : an immunocytochemical study 197
Acetazolamide prevents vacuolar myopathy in skeletal muascle of K+ -depleted rats 196
Migraine and patent foramen ovale: improvement after transcatheteral closure 194
Human skeletal muscle sodium channelopathies 192
Ribonuclear inclusions and MBNL1 nuclear sequestration do not affect myoblast differentiation but alter gene splicing in myotonic dystrophy type 2 191
Muscle surface mechanical and electrical activities in myotonic dystrophy 190
Guidelines on clinical presentation and management of nondystrophic myotonias 190
Cardiac risk and myocardial fibrosis assessment with cardiac magnetic resonance in patients with myotonic dystrophy 189
A multidisciplinary approach improves quality of life perception in patients with amyotrophic lateral sclerosis 189
Complex IV change in the mitochondria respiratory chain of chronic external ophtalmoplegia : a review of our cases 189
Cerebrospinal fluid (CSF) Tau and amyloid Beta42 (AB42) protein abnormalities correlate with executive dysfuction in Myotonic Dystrophy Type 1 (DM1) and Type 2 (DM2) 188
Totale 28.478
Salva come PNG Salva come JPEG
Categoria #
all - tutte 132.317
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 132.317
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.673 0 0 0 121 238 283 293 135 312 371 276 644
2022/20233.956 568 331 369 463 463 697 141 242 366 73 150 93
2023/20242.362 99 189 148 98 509 177 85 150 75 221 246 365
2024/20255.613 280 612 143 441 393 252 257 636 314 511 572 1.202
2025/202612.347 1.112 770 1.308 849 1.051 884 1.348 771 1.287 993 1.140 834
2026/20272.821 795 940 855 231 0 0 0 0 0 0 0 0
Totale 52.262